
Asston Pharmaceuticals Board Approves Auditors, Remuneration
Asston Pharmaceuticals Ltd held a Board Meeting on September 04, 2026, where several key decisions were made. The board approved the appointment of M/s Yash A. Jain & Associates as Internal Auditors and M/s Panchal S K & Associates as Statutory Auditors. Additionally, the re-appointment of Mr. Ashish Narayan Sakalkar as Managing Director was recommended, along with proposed increases in remuneration for Mr. Sakalkar, Mrs. Saili Jayaram More (Whole-time Director and CEO), and Mr. Sachin Chandrakant Badakh (Non-Executive Director), subject to member approval. The Board's Report for the 7th Annual Report (FY26) was approved, and M/s Pragya & Associates was appointed as Scrutinizer for the upcoming 7th Annual General Meeting. The AGM is scheduled for September 29, 2026, with September 22, 2026, set as the cut-off date for e-voting.
Key Highlights
- Appointed new Internal and Statutory Auditors.
- Recommended re-appointment of Managing Director.
- Proposed increased remuneration for MD, CEO, and a Non-Executive Director.
- Approved Board's Report and 7th Annual Report.
- Scheduled 7th Annual General Meeting for September 29, 2026.
Price Impact
More from APL